» Articles » PMID: 37547740

Bulbar Involvement and Cognitive Features in Amyotrophic Lateral Sclerosis: a Retrospective Study on 347 Patients

Abstract

Background: This study aimed at clarifying the role of bulbar involvement (BI) as a risk factor for cognitive impairment (CI) in non-demented amyotrophic lateral sclerosis (ALS) patients.

Methods: Data on = 347 patients were retrospectively collected. Cognition was assessed via the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). On the basis of clinical records and ALS Functional Rating Scale-Revised (ALSFRS-R) scores, BI was characterized as follows: (1) BI at onset-from medical history; (2) BI at testing (an ALSFRS-R-Bulbar score ≤11); (3) dysarthria (a score ≤3 on item 1 of the ALSFRS-R); (4) severity of BI (the total score on the ALSFRS-R-Bulbar); and (5) progression rate of BI (computed as 12-ALSFRS-R-Bulbar/disease duration in months). Logistic regressions were run to predict a below- vs. above-cutoff performance on each ECAS measure based on BI-related features while accounting for sex, disease duration, severity and progression rate of respiratory and spinal involvement and ECAS response modality.

Results: No predictors yielded significance either on the ECAS-Total and -ALS-non-specific or on ECAS-Language/-Fluency or -Visuospatial subscales. BI at testing predicted a higher probability of an abnormal performance on the ECAS-ALS-specific ( = 0.035) and ECAS-Executive Functioning ( = 0.018). Lower ALSFRS-R-Bulbar scores were associated with a defective performance on the ECAS-Memory ( = 0.025). No other BI-related features affected other ECAS performances.

Discussion: In ALS, the occurrence of BI itself, while neither its specific features nor its presence at onset, might selectively represent a risk factor for executive impairment, whilst its severity might be associated with memory deficits.

Citing Articles

T1-relaxation times along the corticospinal tract as a diagnostic marker in patients with amyotrophic lateral sclerosis.

Dierksen F, Geibel J, Albrecht J, Hofer S, Dechent P, Hesse A Front Neuroimaging. 2025; 4:1549727.

PMID: 40017821 PMC: 11865248. DOI: 10.3389/fnimg.2025.1549727.

References
1.
Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006; 66(2):265-7. DOI: 10.1212/01.wnl.0000194316.91908.8a. View

2.
Brooks B, Miller R, Swash M, Munsat T . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9. DOI: 10.1080/146608200300079536. View

3.
Massman P, Sims J, Cooke N, Haverkamp L, Appel V, Appel S . Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996; 61(5):450-5. PMC: 1074039. DOI: 10.1136/jnnp.61.5.450. View

4.
Gorno-Tempini M, Hillis A, Weintraub S, Kertesz A, Mendez M, Cappa S . Classification of primary progressive aphasia and its variants. Neurology. 2011; 76(11):1006-14. PMC: 3059138. DOI: 10.1212/WNL.0b013e31821103e6. View

5.
Consonni M, Rossi S, Cerami C, Marcone A, Iannaccone S, Cappa S . Executive dysfunction affects word list recall performance: Evidence from amyotrophic lateral sclerosis and other neurodegenerative diseases. J Neuropsychol. 2015; 11(1):74-90. DOI: 10.1111/jnp.12072. View